Phase 1 Ascites Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites
AscitesOvarian Neoplasms Malignant
Cancer Institute and Hospital, Chinese Academy of Medical Sciences29 enrolled1 locationNCT07435701
Recruiting
Phase 1Phase 2
Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard Therapy
Malignant ascites
Dong sheng Zhang48 enrolled1 locationNCT07397819
Recruiting
Phase 1Phase 2
Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites
Ascites, MalignantCancer of Stomach, Adenocarcinoma
Qilu Hospital of Shandong University24 enrolled1 locationNCT06759064
Recruiting
Phase 1
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
Cirrhosis, LiverLiver FibrosisAscites Hepatic
PharmaIN74 enrolled9 locationsNCT05490888
Recruiting
Phase 1
A Phase I Study of SIM0388 in Participants With Malignant Ascites.
Malignant ascites
Jiangsu Simcere Pharmaceutical Co., Ltd.50 enrolled1 locationNCT07007988
Recruiting
Phase 1
Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer
Malignant Pleural EffusionMalignant ascites
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)12 enrolled1 locationNCT06016179
Terminated
Phase 1
A phase Ia study of MRC202 in patients with malignant ascites caused by cancer.
Malignant ascites (hydoperitoneum) associated with cancer
MRC Biotech Pty Ltd12 enrolled1 locationACTRN12607000078459